← Back
$CRSP All transactions

CRISPR Therapeutics AG

▲ BUY
10 / 10

Conviction

$ Value

$1.1M

Shares

20,000

Price

$57

Filed

Aug 8

Why this score? (10/10)
  • Open market buy (+3)
  • Trade value >= $1.0M (+2)
  • % of holdings >= 50% (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Treco Douglas A

Title

CIK

0001688192

Roles

Director

Transaction Details

Transaction Date

2025-08-06

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

22,000

Footnotes

Open market purchase of shares in accordance with Issuer's trading policies. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.92 to $57.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Filing Info

Accession No.

0001688192-25-000004

Form Type

4

Issuer CIK

0001674416

Treco Douglas A's History

Date Ticker Type Value
2025-08-06 CRSP $1.1M
2025-07-01 INZY U $175K
2025-07-01 INZY D
2025-07-01 INZY D
2025-07-01 INZY D
2025-06-25 INZY A $2K
2025-06-05 CRSP A $0

Other Insiders at CRSP (90d)

Insider Bought Sold Last
Kulkarni Samarth
Chief Executive Officer
$469K 2026-03-23
KASINGER JAMES R.
General Counsel and Secretary
$149K 2026-03-23
Prasad Raju
Chief Financial Officer
$173K 2026-03-23
Patel Naimish
Chief Medical Officer
2026-03-20